{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002384","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001371730","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"20 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K27ac"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["179"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/772CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"720M","NAME":"S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160309.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/772CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160309.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"1e4923bac4ec9a11ad9ae4ffe74b2df6"},{"FORMAT":"bigBed","SIZE":"1.9M","NAME":"S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160630.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/772CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160630.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"541278bc61922bea157b9e89e377c31a"},{"FORMAT":"BED","SIZE":"2.0M","NAME":"S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160630.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/772CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160630.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"b16fe0e8a6fd30370fbc29bad977e9e6"},{"FORMAT":"Text","SIZE":"2.3M","NAME":"S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160701.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/772CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QV4H1.ERX1347885.H3K27ac.bwa.GRCh38.20160701.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"6040fc031967170fc585a1a638d4668e"}],"dataset_id":"EGAD00001002384","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"772CLL","sample_barcode":"S01QV4H1","attributes":{"DONOR_HEALTH_STATUS":["Chronic Lymphocytic Leukemia"],"DONOR_AGE":["65 - 70"],"MOLECULE":["genomic DNA"],"DISEASE":["Chronic Lymphocytic Leukemia"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0023434"}],"SUBJECT_ID":["772CLL"],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["female"],"DONOR_ID":["772CLL"],"DONOR_SEX":["Female"]},"SAMPLE_ID":"EGAN00001360140","SAMPLE_DESCRIPTION":"Chronic Lymphocytic Leukemia"}}